NCT07715006 Dorsal Root Electrical Stimulation in Children With Cerebral Palsy
| NCT ID | NCT07715006 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Martin Piazza |
| Condition | Cerebral Palsy (CP) |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-07-16 |
| Primary Completion | 2029-11-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-07-16 with a primary completion date of 2029-11-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate whether dorsal root electrical stimulation could reduce spasticity in children with cerebral palsy (CP).
Eligibility Criteria
Inclusion Criteria: * Children ages 3 to 14 * Diagnosis of Cerebral Palsy * Require an SDR as determined by the multidisciplinary movement disorders team * Confirmation that subjects' terms of insurance coverage for their standard of care procedure will not be altered by study enrollment. Exclusion Criteria: * No exclusion criteria
Contact & Investigator
Martin G Piazza, MD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT07715006 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, up to 14 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07715006 currently recruiting?
Yes, NCT07715006 is actively recruiting participants. Contact the research team at mcdonaldbm3@upmc.edu for enrollment information.
Where is the NCT07715006 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07715006 clinical trial?
NCT07715006 is sponsored by Martin Piazza. The principal investigator is Martin G Piazza, MD at University of Pittsburgh. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.